Help pack a million meals for struggling seniors on 9-11. Volunteer today

AARP Bulletin

New Science Sheds Light on the Cause Of Alzheimer’s Disease

Researchers now looking in a new direction for a cure

The brain may try to remove the offending oligomers by forming plaques. Tanzi goes so far as to call the much-vilified plaques “brain pearls.” He says just as an oyster creates a pearl around a grain of sand to protect itself, plaques may serve as traps for microbes that are infecting the brain.

Researchers have found that some people who never had dementia nevertheless have brains coated in plaques. It may be, they theorize, that their brains were exceptionally good at converting the offending “sand” into “pearls.”

Drugs to watch

All this may help explain why research has shown that even though the drug bapineuzumab reduced plaque in the brain, the patients failed to improve. It could also explain the failure of the once-promising Alzhemed drug that discouraged the formation of brain plaques.

Dillin fears we may even discover that drugs designed to break down plaques may speed the disease’s progression.

“I think the plaques are a sign that your brain was trying to do something very beneficial for itself in the last stages of the disease,” he says. “If you go in and take these plaques apart, you’re going to make oligomers, and that could actually be worse.”

On the other hand, Dillin and others say too much protective plaque buildup in the brain may in fact be harmful, interfering with brain function.

Researchers in drug development say there are several Alzheimer’s medications in the pipeline that may work with the new theory.

Tanzi says he suspects the drugs that will work to prevent the disease or at least stop its progression will not entirely destroy the oligomers — he thinks they may play an important role in the brain — but will limit their production.

“Don’t expect to hit oligomers with a sledgehammer and still have the brain be OK,” he warns. Just as statins lower but don’t totally remove cholesterol in the body, he says, we need drugs that will “dial down” the production of the oligomers.

Tanzi is the cofounder of two companies, Neurogenetic Pharmaceutical and Prana Biotechnology, that are developing drugs to do just that.

“The best drugs are yet to come,” Tanzi says. “We’re starting to see some of them in early trials. It’s hard to be patient with a disease like this, but we’ve gone through the first wave of drug failures.”

He compares the first Alzheimer’s drugs to a 10-year-old shooting a soccer ball from midfield. “Now we’ve got a Division I college team driving down the field.”

Not so fast

However, Thies of the Alzheimer’s Association in Chicago is cautious about the new approach to this old disease. He says it’s too soon to eliminate plaques as a drug target. The results of three clinical drug trials “will give us a better handle” on the role of plaques.

Theis says that it could take 10 to 15 years to develop a drug that targets oligomers rather than plaques. There’s a lot of work to be done before this research translates into real help for Alzheimer’s patients, he stresses.

Still, Thies acknowledges that this type of basic science is “critical” and helps move researchers closer to a cure for Alzheimer’s disease.

“The fact is that without adequate support for this kind of basic science, there’s no hope,” he says.

Elizabeth Agnvall is a contributing editor with the AARP Bulletin.

Also of Interest

Visit the AARP home page every day for great deals and for tips on keeping healthy and sharp

Topic Alerts

You can get weekly email alerts on the topics below. Just click “Follow.”

Manage Alerts


Please wait...

progress bar, please wait

Video Extra

MARIA SHRIVER DISCUSSES ALZHEIMER'S: The disease takes a toll on the lives those diagonosed with the disease, and those that care for them. Maria Shriver shares the story of her own family.

Tell Us WhatYou Think

Please leave your comment below.


Discounts & Benefits

From companies that meet the high standards of service and quality set by AARP.

Walgreens 1 discount membership aarp

Members can earn 50 points per $1 spent on select health & wellness products at Walgreens.

member benefit aarp hear usa

Members save 15% on easy listening devices and more at the HearUSA Hearing Shop.

Eye Med 4 Membership Benefit AARP Discount

Members save up to 60% on eye exams and 30% on glasses at Target Optical.

Membership Benefits Discounts Email Genius

Brain boost? Get AARP email for access to memory exercises & more that help you focus.

Rewards for Good

Your Points Balance:

Learn More

Earn points for completing free online activities designed to enrich your life.

Find more ways to earn points

Redeem your points to save on merchandise, travel, and more.

Find more ways to redeem points